BioEcho Limited is a Hong Kong–based medical technology startup developing the world’s first smartwatch-sized, wearable echocardiography system for continuous, real-time cardiac monitoring. BioEcho aims to revolutionize how heart diseases are detected and managed.

Cardiovascular disease remains the leading global cause of death, and current diagnostic ultrasound imaging is confined to hospitals, bulky devices, and trained sonographers. This creates critical gaps in early detection—especially for elderly individuals, high-risk patients, and underserved communities with limited access to specialist care. BioEcho closes this gap by miniaturizing ultrasound hardware into a wrist-worn form factor, integrating flexible sensor patches with high-voltage ultrasound electronics and AI-driven image reconstruction.

Our system enables 24/7 cardiac imaging during daily activities, generating continuous functional and structural heart data that can support early diagnosis of heart failure, myocardial ischemia, arrhythmias, and other life-threatening conditions. Cloud-connected analytics deliver automated alerts to clinicians, caregivers, and users, enabling proactive interventions instead of delayed treatment.

BioEcho’s multidisciplinary team includes engineers, material scientists, and clinical cardiology advisors from HKU, Peking University, and leading medical research institutes. Supported by HKSTP, HKU, and research partnerships with hospitals, we are advancing toward clinical pilots and regulatory pathways (FDA/CE) for medical-grade deployment.

Our mission is simple but transformative: bring echocardiography out of the hospital and into everyday life, enabling preventative, accessible, and intelligent cardiac care for millions worldwide.

組長
Team Leader
田新宇
TIAN Xinyu (HKU)

組員
Team Member
邱韻玲
YAU Wan Ling (HKU)

院校顧問
Faculty Advisor
Mr. Tim CHEUNG (HKU)

Website
https://bioecho.hk/